REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Pharma Korp Pk S.A. (Ecuador)

Main Activities: Offices of Physicians
Secondary Activities: Offices of Dentists | Medical and Diagnostic Laboratories
Full name: Pharma Korp Pk S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Pharma Korp Pk S.A. is based in Ecuador. The head office is in Quito. The company operates in the Offices of Physicians industry. Pharma Korp Pk S.A. was incorporated on June 04, 2019. There are currently 10 (2022) people employed by Pharma Korp Pk S.A.. The company’s latest financial report indicates a net sales revenue increase of 23.34% in 2022. Its total assets grew by 39.4% over the same period. The net profit margin of Pharma Korp Pk S.A. decreased by 13.28% in 2022.

Headquarters
Av. Mariana de Jesus, Gaia Bldg.
Quito; Pichincha;

Contact Details: Purchase the Pharma Korp Pk S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Pharma Korp Pk S.A. report to view the information.
Outstanding Shares:
Purchase the Pharma Korp Pk S.A. report to view the information.
Registered Capital:
Purchase the Pharma Korp Pk S.A. report to view the information.
Incorporation Date:
June 04, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Pharma Korp Pk S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
23.34%▲
Total operating revenue
23.34%▲
Operating profit (EBIT)
-582.82%▼
Net Profit (Loss) for the Period
-13.53%▼
Total assets
39.4%▲
Total equity
205.07%▲
Operating Profit Margin (ROS)
-43.83%▼
Net Profit Margin
-13.28%▼
Return on Equity (ROE)
-166.74%▼
Quick Ratio
5.12%▲
Cash Ratio
0.23%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo